Blogs
Can Zip Co (ASX: ZIP) Maintain Its Breakout Momentum to Clear Near-Term Resistance?
Zip Co is recovering from 2026 lows on record earnings, a buyback, and US growth via Stripe. Technically, it broke a downtrend with support near $2.00. Key risks: credit quality, US concentration, and competition.
Can SRG Global (ASX: SRG) Sustain Its Breakout After Securing $1.85bn of Contracts?
SRG Global (ASX: SRG) surged after securing $1.85 billion of new contracts, upgrading FY26 EBITDA guidance, and initiating FY27 EBITDA guidance of $190m-$200m. Future performance depends on delivering sustained earnings growth across its diversified infrastructure portfolio.
Can Genesis Minerals (ASX: GMD) Sustain Its Cash Flow Momentum and Break Higher?
Genesis Minerals (ASX: GMD) is accelerating production, generating exceptional cash flow, and advancing its Tower Hill growth engine while the stock approaches key breakout levels. We assess fundamentals, catalysts, risks, and technical signals.
VEEM (ASX: VEE) Shares Surge Nearly 19% as Factory Expansion Fuels Growth Optimism
VEEM shares jumped nearly 19% after completing a major factory expansion. The advanced engineering company is growing its marine, defence, and gyrostabiliser businesses through new products, defence contracts, AUKUS-related opportunities, and increased manufacturing capacity to support future earnings growth.
From 2 Cents to 14 Cents: DXN Delivers One of the ASX's Biggest Rallies of 2026
DXN's share price surged from 2 cents to 14 cents in 2026 after winning major AI and telecommunications infrastructure contracts. The modular data centre specialist is expanding globally, with investors betting on strong growth from AI, cloud, and digital infrastructure markets.
Is Alterity Therapeutics (ASX: ATH) Stabilising After Volatility at a Key Technical Level?
Alterity Therapeutics (ASX: ATH) is advancing its lead neurodegeneration drug, ATH434, toward Phase 3 trials. Following positive clinical data and a 1-for-50 share consolidation, the stock is holding key technical support around 0.450, awaiting a potential upside breakout.
Can Hammer Metals (ASX: HMX) Sustain Its Breakout Above Long-Term Resistance?
Hammer Metals, a junior explorer focused on copper, gold and lithium in Queensland and WA, broke above resistance on strong Kalman drilling and a trading halt tied to a potential control deal, though overbought technicals and exploration risk remain.
Has Ardea Resources (ASX: ARL) Identified a Major Support Floor After Its Steep Pullback from Its Highs?
Ardea Resources (ASX: ARL) is an Australian critical minerals developer whose stock has pulled back sharply from 2026 highs, pressured by a DFS delay at its world-class Kalgoorlie Nickel Project, weak nickel prices, and thin institutional support, while technical indicators suggest the $0.50 level may act as a key support floor.
Can Acrow (ASX: ACF) Break Key Resistance Levels Following Its Recent Floor?
Acrow (ASX: ACF) is technically rebounding, balancing record revenue and strong industrial-access growth with falling margins and rising debt. Future performance depends on profitably converting its $256 million pipeline and breaking key resistance near $1.00.
SRJ Technologies (ASX: SRJ) Explodes Higher as Contract Wins Ignite Buying Frenzy
SRJ Technologies has attracted strong investor interest following the securing of multiple energy-sector contracts, including major UAE robotic inspection projects. Growing adoption of BoltEx® technology, expanding Middle East operations, and a strengthening recurring revenue pipeline have boosted confidence in the company's growth outlook.
EBR Systems (ASX: EBR) Slumps to New Lows as Capital Raise Sparks Investor Exit
EBR Systems has fallen sharply after a major capital raise sparked dilution concerns. Despite the sell-off, the company continues to expand the commercialisation of its FDA-approved WiSE CRT heart-failure technology, supported by growing implant volumes, clinical studies, and international regulatory progress.
Cygnus (ASX: CY5) Shares Soar on A$232M Takeover Bid; 60% Premium Sends CY5 Rallying
Cygnus Metals (ASX: CY5) has surged after a A$232 million takeover offer from Central Asia Metals, offering a 60% premium. The company focuses on developing its high-grade Chibougamau Copper-Gold Project in Québec, alongside lithium and base-metal exploration, while expanding resources through drilling and capital raising.
Has Northern Star Resources (ASX: NST) Found a Reliable Long-Term Support Base?
Northern Star Resources (ASX: NST) faces volatility as FY26 operational downgrades clash with strong gold prices and an A$500M buyback. Technically, the stock recently rebounded off key long-term trendline support near A $20, signalling a potential bullish recovery.
Pacgold (ASX: PGO) Surges Over 10% on Major Demerger Plan and Shift in Growth Focus
Pacgold shares jumped more than 10% after unveiling a major demerger that will spin out its North Queensland exploration assets into Manda Resources. The move allows Pacgold to focus on the producing White Dam Gold Operation while retaining exposure to exploration growth, strengthening its position as a gold producer and developer.
Stakk (ASX: SKK) Surges on Growth Momentum After Record Revenue Expansion
Stakk (ASX: SKK) has surged, reporting record $5.52 million in March quarter revenue and 186% growth, driven by its Stakk IQ embedded finance platform. Expanding across Australian and U.S. banks, healthcare, and regulated industries, it secured major contracts, lifting ARR toward A$26 million.
Has Tivan (ASX: TVN) Formed a Sustainable Long-Term Floor?
Tivan (ASX: TVN) develops critical minerals across Australia and Timor-Leste, led by the Speewah Fluorite project. Following a post-feasibility sell-off and rising cash burn, the stock faces a neutral-to-bearish technical outlook ahead of its late-2026 Final Investment Decision.
Is Tamboran Resources Corporation (ASX: TBN) Uptrend Still Intact Following Its Pullback to Support?
Tamboran Resources is a pre-production shale gas developer in the Beetaloo Basin, advancing toward first gas in 2026. Strong drilling results, contracts, and infrastructure progress support its uptrend, though risks remain around execution, funding, and market access beyond initial supply agreements.
Can Australian Mines (ASX: AUZ) Hold Its Breakout and Target Higher Levels?
Australian Mines (ASX: AUZ) is a critical minerals explorer focused on battery metals, rare earths, and gold across Australia and Brazil, advancing projects like Sconi and Flemington while leveraging strong commodity trends and strategic funding to drive its 2026 share price recovery.
Telix Pharmaceuticals (ASX: TLX) Rebounds From Heavy Sell-Off Reignites Investor Optimism
Telix Pharmaceuticals (ASX: TLX) is recovering after a sharp biotech sell-off driven by regulatory and legal concerns. Renewed investor confidence follows strong revenue growth, progress in Phase 3, and a Regeneron partnership, with FY2026 revenue nearing US$1 billion and pipeline milestones advancing.
Is Neuren Pharmaceuticals (ASX: NEU) Poised to Reclaim Higher Levels After Forming a Higher Low?
Neuren Pharmaceuticals (ASX: NEU) is a rare-disease biotech generating revenue from DAYBUE while advancing NNZ-2591. After declines from regulatory and guidance setbacks, improving US rollout and technical strength suggest a recovery, with the stock forming higher lows and testing key resistance levels.
Marmota (ASX: MEU) Share Price Surges as Traders Chase Momentum in South Australia Gold Play
Marmota (ASX: MEU) has surged back into focus after strong gains driven by high-grade drilling results from its Greenewood gold project in South Australia. Renewed exploration activity, rising gold prices, and aggressive drilling have boosted investor interest. The stock remains highly speculative but increasingly watched by ASX momentum traders.